A flood of new state laws now strictly regulates pharmaceutical and medical device companies' interactions with healthcare professionals, and more are on the way. Unlike the Pharmaceutical Research and Manufacturers of America and AdvaMed codes on interactions with healthcare professionals, which are voluntary, these state laws include fines and penalties for noncompliance. And now Congress is considering the Physician Payments Sunshine Act of 2009, which would also require that aggregate spe
How New State Pharma Marketing Laws Could Affect Continuing Medical Education
From California to Massachusetts, states are implementing laws that regulate how pharma and medical device companies interact with physicians.